BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19770310)

  • 1. Pharmacokinetics of (99m)Tc-MAG3.
    Vivier PH; Dacher JN
    AJR Am J Roentgenol; 2009 Oct; 193(4):W361; author reply W362. PubMed ID: 19770310
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient.
    Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R
    Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of
    Arteaga MV; Caballero VM; Rengifo KM
    Appl Radiat Isot; 2018 Aug; 138():25-28. PubMed ID: 28781122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reproducibility of measurements of differential renal function in paediatric 99mTc-MAG3 renography: is this correct?
    Sabour S; Ghassemi F
    Nucl Med Commun; 2012 Dec; 33(12):1311; author reply 1311-2. PubMed ID: 22972373
    [No Abstract]   [Full Text] [Related]  

  • 6. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function.
    Itoh K
    Ann Nucl Med; 2001 Jun; 15(3):179-90. PubMed ID: 11545186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography.
    Jung HS; Chung YA; Kim EN; Kim SH; Lee SY; Sohn HS; Park YH; Chung SK
    Ann Nucl Med; 2005 Feb; 19(1):1-7. PubMed ID: 15770966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
    Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
    AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of quantitative parameters in (99m) Tc-MAG3 dynamic renography: a national audit based on virtual image data.
    Brolin G; Edenbrandt L; Granerus G; Olsson A; Afzelius D; Gustafsson A; Jonsson C; Hagerman J; Johansson L; Riklund K; Ljungberg M
    Clin Physiol Funct Imaging; 2016 Mar; 36(2):146-54. PubMed ID: 25348641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic difficulty in interpretation of Tc-99m MAG3 dynamic renal scan: intrarenal reflux or delayed concentration function?
    Karacalioglu O; Ilgan S; Arslan N; Ozguven MA; Dayanc M
    Clin Nucl Med; 2004 Jun; 29(6):382-5. PubMed ID: 15166890
    [No Abstract]   [Full Text] [Related]  

  • 11. Administered activity optimization in 99mTc-MAG3 renography for adults.
    Díaz MP; Aparicio EE; Rizo OD; Díaz RR; Rodríguez CH
    J Nucl Med Technol; 2003 Dec; 31(4):216-21. PubMed ID: 14657288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral vesicoureteral reflux detected by diuretic renography without voiding.
    Tsuchimochi S; Nakajo M; Tanabe H; Jinguji M; Nakabeppu Y; Tani A
    Clin Nucl Med; 2003 Mar; 28(3):228-9. PubMed ID: 12592134
    [No Abstract]   [Full Text] [Related]  

  • 13. Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular model.
    Nový Z; Mandíková J; Trejtnar F
    Ceska Slov Farm; 2011 Feb; 60(1):7-10. PubMed ID: 21648170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Tc 99m mercaptoacetyl-triglycine (MAG3) renography as an evaluator of early renal transplant function.
    Carmody E; Greene A; Brennan P; Donohue J; Carmody M; Keeling F
    Clin Transplant; 1993 Jun; 7(3):245-9. PubMed ID: 10148844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetazolamide assisted Tc-99m MAG3 renography to assess renal blood flow reserve.
    Horita Y; Hayashida K; Fukuchi K; Takishita S; Tadokoro M; Taura K; Suyama N; Miyazaki M; Kohno S; Kawano Y
    Ann Nucl Med; 2003 Apr; 17(2):139-44. PubMed ID: 12790363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian 3-compartment model for 99mTc-MAG3 clearance.
    Russell CD
    J Nucl Med; 2003 Aug; 44(8):1357-61. PubMed ID: 12902428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
    Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
    Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free technetium: potential pitfall in the diagnosis of renovascular hypertension.
    Hunsche A; Grossman GB; Galt JR; Halkar RK
    Clin Nucl Med; 2004 Mar; 29(3):218-21. PubMed ID: 15163000
    [No Abstract]   [Full Text] [Related]  

  • 19. Interobserver agreement on cortical tracer transit in 99mTc-MAG3 renography applied to congenital hydronephrosis.
    Santos AI; Violante L; Carmona S; Prata A; Rodrigues Victor M; Santos JG; Araújo Sequeira J; Alves M; Papoila AL; Piepsz A
    Nucl Med Commun; 2017 Feb; 38(2):124-128. PubMed ID: 27851658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity.
    Nimmon CC; Sámal M; Britton KE
    J Nucl Med; 2004 Apr; 45(4):587-93. PubMed ID: 15073254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.